Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments 

Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth

AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform

Coherus Divests UDENYCA Franchise to Intas in $558.4M Deal to Fund Immuno-Oncology Expansion

COUR Pharmaceuticals Secures $40M Upfront in Genentech Deal, Potential Milestones Exceed $900M

BioFuse Medical Technologies Appoints Rick Early as CEO

Velentium Appoints Matt Hanks as CEO, Co-Founder Dan Purvis Named Board Chair to Propel Growth

Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough

Zenflow Secures $24M in Sercies C- Funding

Nobias Therapeutics Appoints Patrick Dougherty as CEO to Lead Next Phase of Growth

Metsera Secures $215M in Series B Funding to Advance Obesity and Metabolic Disease Portfolio

Julie Eastland Appointed CEO of Zentalis Pharmaceuticals to Lead Advancement of Azenosertib in Oncology

Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio

Axonis Therapeutics Secures $115M Series A to Advance Neuromedicine Pipeline

Celltex Therapeutics Welcomes Anita Perry as CEO 

Alpha-9 Oncology Secures $175M Series C to Drive Radiopharmaceutical Innovation in Cancer Treatment

I-Mab Appoints Dr. Sean Fu as Permanent CEO to Lead Advancement of Cancer Immunotherapy Programs

AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio